Meta-genotype Determination System for Genetic Assay Integration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genetic assays often fail to provide comprehensive information needed for technological objectives such as blood typing, genetic profiling for drug responsiveness, and characterization of stem cell pluripotency, necessitating the combination of data from multiple assays.

Innovation Solution

A computer-implemented method and system that receive nucleic acid amplification data from biological samples, store and compare translation data to generate meta-genotypes, and display the results, enabling the determination of genetic patterns and meta-genotypes for various applications like blood typing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If multiple genetic assays are used to determine comprehensive genetic results, then the completeness and accuracy of genetic information is improved, but the complexity of data integration and result determination worsens

Engineering Contradiction:
Improvegenetic information completenessVSAvoiddata integration complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple genetic assay results into a unified meta-genotype determination system. The system integrates data from multiple assays (e.g., ABO blood group assay, Rh blood group assay) and merges them to determine comprehensive blood type information, resolving the complexity of handling multiple separate assays through a unified computational framework.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent introduces a computational system as an intermediary between raw genetic assay data and final genetic results. This intermediary system processes, integrates, and interprets data from multiple assays using algorithms and databases, simplifying the complex task of data integration and result determination while maintaining high accuracy.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If multiple genetic assays are performed to achieve comprehensive genetic profiling, then the reliability of genetic results is improved, but the time and resources required worsen

Engineering Contradiction:
Improvegenetic result accuracyVSAvoidassay processing time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent implements preliminary action by pre-processing and organizing genetic assay data into standardized formats before integration. The system prepares data structures, validates inputs, and organizes assay results in advance, which streamlines the subsequent integration process and reduces overall processing time while maintaining reliability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent ensures continuity of useful action by implementing an automated computational pipeline that continuously processes genetic assay data from multiple sources. The system maintains continuous operation in integrating and analyzing data streams, eliminating idle time and ensuring efficient utilization of resources throughout the genetic profiling process.

Inventive Principle:
Principle #20Continuity of useful action

Data Source

PatentUS10007753B2Methods and systems for determining meta-genotypes
Publication Date: 2018.06.26 LIFE TECHNOLOGIES CORP
  • US10007753B2 patent drawing
  • US10007753B2 patent drawing
  • US10007753B2 patent drawing

AI summary

In one exemplary embodiment, a computer-implemented method for determining a genetic result from a biological sample is provided. The method includes receiving nucleic acid amplification data of a biological sample, by a processor, from a biological instrument. The method further includes storing translation data, in a memory. The translation data includes a pattern of assay values associated with possible genetic results. The method further includes comparing the translation data with the nucleic acid amplification data, by the processor, to generate the genetic result of the biological sample. Moreover, the method includes displaying the genetic result, on a display, to a user.